When one becomes many-Alternative splicing in β-cell function and failure.
Maria Inês AlvelosJonàs Juan-MateuMaikel Luis ColliJean-Valéry TuratsinzeDécio L EizirikPublished in: Diabetes, obesity & metabolism (2019)
Pancreatic β-cell dysfunction and death are determinant events in type 1 diabetes (T1D), but the molecular mechanisms behind β-cell fate remain poorly understood. Alternative splicing is a post-transcriptional mechanism by which a single gene generates different mRNA and protein isoforms, expanding the transcriptome complexity and enhancing protein diversity. Neuron-specific and certain serine/arginine-rich RNA binding proteins (RBP) are enriched in β-cells, playing crucial roles in the regulation of insulin secretion and β-cell survival. Moreover, alternative exon networks, regulated by inflammation or diabetes susceptibility genes, control key pathways and processes for the correct function and survival of β-cells. The challenge ahead of us is to understand the precise role of alternative splicing regulators and splice variants on β-cell function, dysfunction and death and develop tools to modulate it.
Keyphrases
- type diabetes
- induced apoptosis
- oxidative stress
- genome wide
- cell cycle arrest
- cell fate
- single cell
- cardiovascular disease
- gene expression
- transcription factor
- glycemic control
- binding protein
- nitric oxide
- endoplasmic reticulum stress
- protein protein
- rna seq
- signaling pathway
- adipose tissue
- genome wide identification
- mesenchymal stem cells
- cell proliferation
- metabolic syndrome
- heat shock